Plasmid-based short hairpin RNA against connective tissue growth factor attenuated monocrotaline-induced pulmonary vascular remodeling in rats

Gene Therapy

Volumn 21, Issue 11, 2014, Pages 931-937

  Wang, R ^a   Zhou, S J ^a,b   Zeng, D X ^c   Xu, R ^a   Fei, L M ^a   Zhu, Q Q ^a   Zhang, Y ^a   Sun, G Y ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Hefei Center for Disease Control and Prevention   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MONOCROTALINE; SHORT HAIRPIN RNA; CTGF PROTEIN, RAT; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; LUNG BLOOD VESSEL; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PULMONARY VASCULAR DISEASE; RAT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; HYPERTENSION, PULMONARY; MALE; METABOLISM; PATHOLOGY; PULMONARY ARTERY; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; VASCULAR REMODELING;

EID: 84910136670     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2014.62     Document Type: Article

References (27)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-1436.
2. Pidgeon GP, Tamosiuniene R, Chen G, Leonard I, Belton O, Bradford A et al. Intravascular thrombosis after hypoxia-induced pulmonary hypertension - regulation by cyclooxygenase-2. Circulation 2004; 110: 2701-2707.
3. Peinado VI, Pizarro S, Barbera JA. Pulmonary vascular involvement in COPD. Chest 2008; 134: 808-814.
4. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2012; 122: 4306-4313.
5. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285-1294.
6. Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999; 19: 2958-2966.
7. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Fujii T, Luscher TF. Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999; 100: 2108-2112.
8. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 1999; 126: 137-145.
9. Takigawa M. CTGF/Hcs24 as a multifunctional growth factor for fibroblasts, chondrocytes and vascular endothelial cells. Drug News Perspect 2003; 16: 11-21.
10. Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa M. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro . J Cell Physiol 2000; 184: 197-206.
11. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J et al. Connective tissue growth factor is crucial to inducing a profibrotic environment in 'fibrosis-resistant' BALB/c mouse lungs. Am J Respir Cell Mol Biol 2004; 31: 510-516.
12. Tian F, Xu YJ, Zhang ZX, Fan XL, Hu J. Role of connective tissue growth factor on pulmonary artery remodeling in rats exposed to smoke. Zhonghua Jie He He Hu Xi Za Zhi 2007; 30: 921-925.
13. Wang R, Xu YJ, Liu XS, Zeng DX, Xiang M. Knockdown of connective tissue growth factor by plasmid-based short hairpin RNA prevented pulmonary vascular remodeling in cigarette smoke-exposed rats. Arch Biochem Biophys 2011; 508: 93-100.
14. Wang R, Xu YJ, Liu XS, Zeng DX, Xiang M. CCN2 promotes cigarette smoke-induced proliferation of rat pulmonary artery smooth muscle cells through upregulating cyclin D1 expression. J Cell Biochem 2012; 113: 349-359.
15. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C. The CCN family: a new class of inflammation modulators? Biochimie 2011; 93: 377-388.
16. Branchetti E, Poggio P, Sainger R, Shang E, Grau JB, Jackson BM et al. Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res 2013; 100: 316-324.
17. Gao DF, Niu XL, Hao GH, Peng N, Wei J, Ning N et al. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis. Biochem Pharmacol 2007; 73: 185-197.
18. Wang RD, Wright JL, Churg A. Transforming growth factor-beta(1) drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005; 33: 387-393.
19. Fan WH, Pech M, Karnovsky MJ. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 2000; 79: 915-923.
20. Li G, Hu Y, Jia P, Fu J, Lu CX, Sun YQ et al. Integrin beta3 pathway mediated connective tissue growth factor-induced proliferation, migration and extracellular matrix deposition of pulmonary arterial smooth muscle cells. Zhonghua Er Ke Za Zhi 2011; 49: 895-900.
21. Kubota S, Hattori T, Shimo T, Nakanishi T, Takigawa M. Novel intracellular effects of human connective tissue growth factor expressed in Cos-7 cells. FEBS Lett 2000; 474: 58-62.
22. Chien W, Yin D, Gui D, Mori A, Frank JM, Said J et al. Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells. Mol Cancer Res 2006; 4: 591-598.
23. Sakai Y, Balam TA, Kuroda S, Tamamura N, Fukunaga T, Takigawa M et al. CTGF and apoptosis in mouse osteocytes induced by tooth movement. J Dent Res 2009; 88: 345-350.
24. Hadri L, Kratlian RG, Benard L, Maron BA, Dorfmuller P, Ladage D et al. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension. Circulation 2013; 128: 512-523.
25. Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB. Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 2004; 110: 1499-1506.
26. Yuan P, Wu WH, Gao L, Zheng ZQ, Liu D, Mei HY et al. Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways. Eur Respir J 2013; 41: 1116-1125.
27. Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P et al. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 2009; 15: 1289-1297.